Recent years have witnessed notable progress in tailoring treatments for solid tumors using biomarkers. Nevertheless, identifying specific biomarkers for ...

The authors examine the role of Numb, a Notch inhibitor, in intestinal stem cell self-renewal in Drosophila during homeostasis and regeneration. This is an important study providing evidence of a Numb ...

Anxiety disorders, characterized by an excessive apprehension about real or perceived threats and dysfunctional behaviors ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming catalysts for ...

Phosphoproteomics unveils the mode of action of clinical ATR inhibitors and explains their synergy with Gemcitabine in ...

Cartalax peptide, a bioregulator derived from cartilage tissue, has garnered significant interest in scientific communities ...

A novel geometric deep learning framework designs ligand-specific protein binders, enhancing therapeutic potential in cell ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Aberrant activation of the Ras/Raf/MAPK/ERK kinase/extracellular signal-regulated kinase cascade and the VEGF pathway are commonly observed in breast cancer cells leading to malignant cell ...

Jan. 24, 2025 — A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at ...

Immunology is the branch of biomedical sciences concerned with all aspects of the immune system in all multicellular organisms. On 23–26 September 2024, the second ImmunOctoberfest conference ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.